1. Curcumin suppresses cisplatin resistance development partly via modulating extracellular vesicle-mediated transfer of MEG3 and miR-214 in ovarian cancer
    Jing Zhang et al, 2017, Cancer Chemother Pharmacol CrossRef
  2. Neighborhood and Family Environment of Expectant Mothers May Influence Prenatal Programming of Adult Cancer Risk: Discussion and an Illustrative DNA Methylation Example
    Katherine E. King et al, 2016, Biodemography and Social Biology CrossRef
  3. UCA1 functions as a competing endogenous RNA to suppress epithelial ovarian cancer metastasis
    Yijun Yang et al, 2016, Tumor Biol. CrossRef
  4. LncRNAs and neoplasia.
    Mustafa Isin et al, 2015, Clin. Chim. Acta CrossRef
  5. Functional prediction of long non-coding RNAs in ovarian cancer-associated fibroblasts indicate a potential role in metastasis
    Fatemeh Vafaee et al, 2017, Sci Rep CrossRef
  6. Long non-coding RNAs in hepatocellular carcinoma: Potential roles and clinical implications
    Zhao-Shan Niu et al, 2017, WJG CrossRef
  7. Promoter hypermethylation-mediated downregulation of miR-770 and its host gene MEG3, a long non-coding RNA, in the development of gastric cardia adenocarcinoma
    Wei Guo et al, 2017, Mol Carcinog CrossRef
  8. LncRNA MEG3 inhibit endometrial carcinoma tumorigenesis and progression through PI3K pathway
    Kai-Xuan Sun et al, 2017, Apoptosis CrossRef
  9. Multiple Functions of Long Non-Coding RNAs in Oxidative Stress, DNA Damage Response and Cancer Progression
    Sadra Samavarchi Tehrani et al, 2018, J. Cell. Biochem. CrossRef
  10. Knockdown of lncRNA MEG3 inhibits viability, migration, and invasion and promotes apoptosis by sponging miR-127 in osteosarcoma cell
    Yang Wang et al, 2018, J. Cell. Biochem. CrossRef
  11. Expression and clinical role of long non-coding RNA in high-grade serous carcinoma
    Natalie Filippov-Levy et al, 2018, Gynecologic Oncology CrossRef
  12. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
    Jia Li et al, 2016, Int J Oncol CrossRef
  13. Microarray expression profiling of long non-coding RNAs in epithelial ovarian cancer
    Ye Ding et al, 2017 CrossRef
  14. TPGLDA: Novel prediction of associations between lncRNAs and diseases via lncRNA-disease-gene tripartite graph
    Liang Ding et al, 2018, Sci Rep CrossRef
  15. Human exposure to flame-retardants is associated with aberrant DNA methylation at imprinted genes in sperm
    Adelheid Soubry et al, 2017 CrossRef
  16. Differential long non-coding RNA expression profiles in human oocytes and cumulus cells
    Julien Bouckenheimer et al, 2018, Sci Rep CrossRef
  17. Non-Coding RNAs and Endometrial Cancer
    Cristina Vallone et al, 2018, Genes CrossRef
  18. Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes
    Manish K. Tripathi et al, 2018, Drug Discovery Today CrossRef
  19. Interplay between regulation by methylation and noncoding RNAs in cancers
    Chun-Xiao Lu et al, 2018, European Journal of Cancer Prevention CrossRef
  20. Long non-coding RNAs in ovarian cancer
    Lei Zhan et al, 2018, J Exp Clin Cancer Res CrossRef
  21. LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN.
    Juelan Wang et al, 2018, Inflamm Res CrossRef
  22. Integrating Multiple Heterogeneous Networks for Novel LncRNA-Disease Association Inference.
    Jingpu Zhang et al, 2019, IEEE/ACM Trans Comput Biol Bioinform CrossRef
  23. A genomic screen for long noncoding RNA genes epigenetically silenced by aberrant DNA methylation in colorectal cancer
    Kohei Kumegawa et al, 2016, Sci Rep CrossRef
  24. Association of long non‐coding RNA MEG3 polymorphisms with oral squamous cell carcinoma risk
    Yunwen Hou et al, 2019, Oral Dis CrossRef
  25. The role of lncRNAs in hepatocellular carcinoma: opportunities as novel targets for pharmacological intervention
    Hai Zou et al, 2016, Expert Review of Gastroenterology & Hepatology CrossRef
  26. LncRNAs: key players and novel insights into cervical cancer.
    Li Peng et al, 2016, Tumour Biol CrossRef
  27. Expression and mechanisms of long non-coding RNA genes MEG3 and ANRIL in gallbladder cancer
    Bo Liu et al, 2016, Tumor Biol. CrossRef
  28. HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer
    Yiqing Chai et al, 2016, Cancer Med CrossRef
  29. Dysregulated Expression of Long Noncoding RNAs in Ovarian Cancer
    Yancheng Zhong et al, 2016, Int J Gynecol Cancer CrossRef
  30. Downregulation of long noncoding RNA MEG3 is associated with poor prognosis and promoter hypermethylation in cervical cancer
    Jun Zhang et al, 2017, J Exp Clin Cancer Res CrossRef
  31. Dysregulated expression of long noncoding RNAs in gynecologic cancers
    Elahe Seyed Hosseini et al, 2017, Mol Cancer CrossRef
  32. Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum
    Selin Oncul et al, 2019, RNA Biology CrossRef
  33. A comprehensive review of the role of long non-coding RNAs in organs with an endocrine function
    Soudeh Ghafouri-Fard et al, 2020, Biomedicine & Pharmacotherapy CrossRef
  34. Deciphering the Mounting Complexity of the p53 Regulatory Network in Correlation to Long Non-Coding RNAs (lncRNAs) in Ovarian Cancer.
    Sonali Pal et al, 2020, Cells CrossRef
  35. Clinical Value of lncRNA MEG3 in High-Grade Serous Ovarian Cancer
    Marianna Buttarelli et al, 2020, Cancers CrossRef
  36. Improved method for prioritization of disease associated lncRNAs based on ceRNA theory and functional genomics data
    Peng Wang et al, 2017, Oncotarget CrossRef
  37. Long noncoding RNA MEG3, a potential novel biomarker to predict the clinical outcome of cancer patients: a meta-analysis.
    Xiangrong Cui et al, 0 CrossRef
  38. Potential applications of MEG3 in cancer diagnosis and prognosis
    Yuqing He et al, 2017, Oncotarget CrossRef
  39. An overview of long non-coding RNAs in ovarian cancers
    Matthieu Meryet-Figuière et al, 2016, Oncotarget CrossRef
  40. Construction and analysis of lncRNA-lncRNA synergistic networks to reveal clinically relevant lncRNAs in cancer
    Yongsheng Li et al, 2015, Oncotarget CrossRef
  41. LncRNA MEG3 suppressed the progression of ovarian cancer via sponging miR-30e-3p and regulating LAMA4 expression
    Yang Liu et al, 2020, Cancer Cell Int CrossRef
  42. Identification of aberrantly expressed long non‐coding RNAs in ovarian high‐grade serous carcinoma cells
    Kengo Nakashima et al, 2020, Reprod Med Biol CrossRef
  43. LINC01224 Exhibits Cancer-Promoting Activity in Epithelial Ovarian Cancer Through microRNA-485-5p-Mediated PAK4 Upregulation

    Shujian Xing et al, 2020, OTT CrossRef
  44. Expression of ncRNAs on the DLK1-DIO3 Locus Is Associated With Basal and Mesenchymal Phenotype in Breast Epithelial Progenitor Cells
    Zuzana Budkova et al, 2020, Front. Cell Dev. Biol. CrossRef
  45. Promoter hypermethylation influences the suppressive role of long non‑coding RNA MEG3 in the development of multiple myeloma
    Wenjun Yu et al, 2020, Exp Ther Med CrossRef
  46. Role of DNA Methylation in the Resistance to Therapy in Solid Tumors.
    Susana Romero-Garcia et al, 2020, Front Oncol CrossRef
  47. Application of multiomics sequencing and advances in the molecular mechanisms of pancreatic neuroendocrine neoplasms
    Rui Jiang et al, 2020, Cancer Letters CrossRef
  48. LncRNAs in Ovarian Cancer Progression, Metastasis, and Main Pathways: ceRNA and Alternative Mechanisms
    Eleonora A. Braga et al, 2020, IJMS CrossRef
  49. Aberrant Methylation-Mediated Silencing of lncRNA MEG3 Functions as a ceRNA in Esophageal Cancer
    Zhiming Dong et al, 2017, Mol Cancer Res CrossRef
  50. A cross–nearest neighbor/Monte Carlo algorithm for single-molecule localization microscopy defines interactions between p53, Mdm2, and MEG3
    Nicholas C. Bauer et al, 2021, Journal of Biological Chemistry CrossRef
  51. An Overview of the Role of Long Non-Coding RNAs in Human Choriocarcinoma.
    Maja Sabol, 0 CrossRef
  52. Mutated p53 in HGSC—From a Common Mutation to a Target for Therapy
    Aya Saleh et al, 2021, Cancers CrossRef
  53. null
    Nirupama Sabnis et al, 2021 CrossRef
  54. (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers.
    Maja Sabol, 0 CrossRef
  55. null
    Seyed Mohammad Kazem Aghamir et al, 2022 CrossRef
  56. UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis
    Zhong-Feng Huang et al, 2022, Molecular Therapy - Oncolytics CrossRef
  57. Long Non-Coding RNA-Based Functional Prediction Reveals Novel Targets in Notch-Upregulated Ovarian Cancer
    Seonhyang Jeong et al, 2022, Cancers CrossRef
  58. The Regulatory Functions and the Mechanisms of Long Non-Coding RNAs in Cervical Cancer
    Qiwei Yang et al, 2022, Cells CrossRef
  59. Role of Cancer-Associated fibroblast in the pathogenesis of ovarian Cancer: Focus on the latest therapeutic approaches
    Haigang Ding et al, 2022, International Immunopharmacology CrossRef
  60. Hypermethylation of Long Non-Coding RNA Genes Group in the Breast Cancer Development and Progression
    A. D. Selezneva et al, 2022, Bull Exp Biol Med CrossRef